Biodeal Pharmaceuticals concludes successful Piramal Alternatives partnership
Piramal Alternatives announced the successful conclusion of the investment made by its fund, Piramal Structured Credit…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Thai FDA approves NUZOLVENCE just six months after US authorisation
The GARDP Foundation (known as GARDP) and Dr Reddy's Laboratories announced that the Thai Food and Drug Administration (FDA) has…
Immuneel Therapeutics and THSTI announce strategic partnership to advance CAR-T cell therapy and…
Immuneel Therapeutics Private Limited and the BRIC Translational Health Science and Technology Institute (THSTI) have officially…
End of OTC cough syrups: Should more medicines move behind the prescription wall?
Why the regulation matters
This recent move to limit the sale of some cough syrups over-the-counter (OTC) is an essential…
Future of MP Pharma lies in quality manufacturing, exports and contract development
Madhya Pradesh is steadily emerging as a pharma manufacturing hub. How do you assess the current growth trajectory of the state's…
India’s online pharmacy boom and the perils of unregulated medicine
Online shopping has trained us to value one thing above all others: visibility. Yet what empowers a consumer comparing prices…
FDD Leadership Awards spotlight FR&D excellence
Continuing its tradition of recognising excellence, the FDD Leadership Awards 2026, held alongside the FDD Conclave 2026,…
FDD Conclave 2026: Charting the future of formulation science and drug delivery
The pharma industry is entering an era where scientific innovation must move faster, scale smarter and remain affordable. Against…
How AI is redefining India’s pharmaceutical export edge
India's pharmaceutical industry has gained an international reputation due to its large-scale production, advanced scientific…
Sun Pharma notes Organon shareholder approval for proposed acquisition
Sun Pharmaceutical Industries announced that the stockholders of Organon have approved the proposals in connection with the…
Akums to acquire Oriflame India’s manufacturing business
Akums Drugs and Pharmaceuticals ("Akums" or "the Company"), India's largest Contract Development and Manufacturing Organisations…
Chhattisgarh draws ₹992.53 crore pharma investment proposals in 18 months
Riding on policy reforms that earned it the top rank among large states in NITI Aayog's Investment Friendliness Index 2026 for…
The innovation litmus test
Every industry eventually reaches a point where yesterday's biggest strength is no longer tomorrow's biggest differentiator. For…
Redefining pharma warehousing: The shift from storage facilities to compliance-driven supply chain…
Pharmaceutical warehousing has evolved significantly from a backend storage function to a critical component of regulated supply…
Hikal commissions cGMP pilot plant in Pune to scale-up capabilities
Hikal, a leading partner to global pharmaceutical, crop protection and specialty chemical companies, has announced the successful…
Trump’s proposed generic drug tariffs trigger caution, industry sees limited near-term impact
US President Donald Trump has proposed a phased tariff framework for imported generic pharmaceuticals, under which generic drugs…
Why India’s biopharma value shift could unlock an additional $125-bn opportunity
What are the broad global consumer health trends driving the global biopharma sector this decade?
We believe that global…
Primus Partners launches thought leadership report highlighting nearly ₹48,000 crore annual pharma…
Primus Partners, India's leading management consulting firm, released its latest thought leadership report, "The Leaking Pipeline:…
India has emerged as a strategically important hub for Merck
Since its expansion, how has the Peenya facility contributed to strengthening Merck's manufacturing footprint in the Asia-Pacific…
Biopharma 4.0: How Ireland and India can shape the next era of smart manufacturing
The global biopharma sector is entering a moment where the old rules of competitiveness are being rewritten. For decades, market…